标题
Nanotechnology in Drug Delivery for Liver Fibrosis
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-11
DOI
10.3389/fmolb.2021.804396
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
- (2021) Mengying Hu et al. Nature Nanotechnology
- Role of liver sinusoidal endothelial cells in liver diseases
- (2021) Jordi Gracia-Sancho et al. Nature Reviews Gastroenterology & Hepatology
- Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia
- (2021) Jordi Ribera et al. ACS Nano
- Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis
- (2021) Matthias Bartneck ADVANCED DRUG DELIVERY REVIEWS
- Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
- (2021) Virender Kumar et al. ADVANCED DRUG DELIVERY REVIEWS
- Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe
- (2021) Ariya Saraswathy et al. Scientific Reports
- Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
- (2020) Liteng Lin et al. Advanced Science
- Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
- (2020) Clara I. Colino et al. Frontiers in Immunology
- Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
- (2020) Eliana B. Souto et al. Pharmaceutics
- Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities
- (2020) Jinfang Zhang et al. ACS Nano
- Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis
- (2020) Jian-Bin Qiao et al. JOURNAL OF CONTROLLED RELEASE
- Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis
- (2020) Hongxia Liang et al. Nano Research
- Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
- (2020) De Ji et al. JOURNAL OF NANOBIOTECHNOLOGY
- Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
- (2020) Lei Hou et al. Frontiers in Immunology
- Progress in drug delivery system for fibrosis therapy
- (2020) Lei Xing et al. Asian Journal of Pharmaceutical Sciences
- Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
- (2020) Yankai Wen et al. Cellular & Molecular Immunology
- Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals
- (2020) Qi Liu et al. ACS Nano
- Myeloid cell‐specific IL‐6 signaling promotes miR‐223‐enriched exosome production to attenuate NAFLD‐associated fibrosis
- (2020) Xin Hou et al. HEPATOLOGY
- Engineered Relaxin as Theranostic nanomedicine to diagnose and ameliorate liver cirrhosis
- (2019) Beata Nagórniewicz et al. Nanomedicine-Nanotechnology Biology and Medicine
- Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis
- (2019) Jingwen Luo et al. ACS Nano
- An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
- (2019) Yanping Li et al. JOURNAL OF CONTROLLED RELEASE
- Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
- (2019) Mengying Hu et al. Nature Communications
- TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
- (2019) Dewidar et al. Cells
- Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
- (2018) Devaraj Ezhilarasan et al. Hepatobiliary & Pancreatic Diseases International
- Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis
- (2018) Jian-Bin Qiao et al. JOURNAL OF CONTROLLED RELEASE
- Clinical phase 1b study results for safety, pharmacokinetics and efficacy of ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 SIRNA for the treatment of Japanese patients with advanced liver fibrosis
- (2018) N. Sakamoto et al. JOURNAL OF HEPATOLOGY
- Risk assessment of silica nanoparticles on liver injury in metabolic syndrome mice induced by fructose
- (2018) Jianmei Li et al. SCIENCE OF THE TOTAL ENVIRONMENT
- The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles
- (2018) Yunfang Li et al. RSC Advances
- Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis
- (2018) Fei Peng et al. ACS Applied Materials & Interfaces
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
- (2018) Maurizio Parola et al. MOLECULAR ASPECTS OF MEDICINE
- Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells
- (2018) Jie Tee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
- (2018) Changyu Zhu et al. Science Translational Medicine
- Oral Exposure to Silver Nanoparticles or Silver Ions May Aggravate Fatty Liver Disease in Overweight Mice
- (2017) Jianbo Jia et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- The origin of fibrogenic myofibroblasts in fibrotic liver
- (2017) Tatiana Kisseleva HEPATOLOGY
- Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- CD44 is a key player in non-alcoholic steatohepatitis
- (2017) Stéphanie Patouraux et al. JOURNAL OF HEPATOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Liver Sinusoidal Endothelial Cell: An Update
- (2017) Ana Maretti-Mira et al. SEMINARS IN LIVER DISEASE
- Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
- (2017) Young-Sun Lee et al. Scientific Reports
- Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice
- (2016) Feng Li et al. BIOMATERIALS
- Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
- (2016) Xiaobo Wang et al. Cell Metabolism
- Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
- (2016) Sook In Chung et al. JOURNAL OF HEPATOLOGY
- Clinical Advancements in the Targeted Therapies against Liver Fibrosis
- (2016) Ruchi Bansal et al. MEDIATORS OF INFLAMMATION
- Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with 99mTc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice
- (2016) Deliang Zhang et al. Scientific Reports
- Pathobiology of liver fibrosis: a translational success story
- (2015) Youngmin A Lee et al. GUT
- Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
- (2015) Tian Lan et al. PLoS One
- The global burden of liver disease: a challenge for methods and for public health
- (2014) Peter Byass BMC Medicine
- Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis
- (2014) Michaela Granzow et al. HEPATOLOGY
- Macrophage heterogeneity in liver injury and fibrosis
- (2014) Frank Tacke et al. JOURNAL OF HEPATOLOGY
- Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- (2014) Y. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Origin of myofibroblasts in the fibrotic liver in mice
- (2014) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
- (2013) Chunbai He et al. BIOMATERIALS
- Specific gene delivery to liver sinusoidal and artery endothelial cells
- (2013) T. Abel et al. BLOOD
- Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo
- (2013) Jonathan A. Fallowfield et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy
- (2013) Virginia Hernández-Gea et al. JOURNAL OF HEPATOLOGY
- Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
- (2013) A. Wehr et al. JOURNAL OF IMMUNOLOGY
- Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
- (2013) Bi-Sen Ding et al. NATURE
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Macrophage microvesicles induce macrophage differentiation and miR-223 transfer
- (2012) N. Ismail et al. BLOOD
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
- (2012) Juliane S. Troeger et al. GASTROENTEROLOGY
- Retinoic acids and hepatic stellate cells in liver disease
- (2012) Young-Sun Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
- (2012) Andreas Glässner et al. LABORATORY INVESTIGATION
- Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
- (2011) Guanhua Xie et al. GASTROENTEROLOGY
- Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice
- (2011) Won-Il Jeong et al. HEPATOLOGY
- Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor–beta on hepatic fibrosis in rats
- (2011) Feng Li et al. JOURNAL OF CONTROLLED RELEASE
- IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF- -Independent Smad Signaling
- (2011) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
- (2011) George M. Philips et al. PLoS One
- Anti-PDGF-B monoclonal antibody reduces liver fibrosis development
- (2010) Shinji Ogawa et al. HEPATOLOGY RESEARCH
- Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles
- (2010) Yuichi Ohya et al. JOURNAL OF CONTROLLED RELEASE
- Hedgehog signaling in the liver
- (2010) Alessia Omenetti et al. JOURNAL OF HEPATOLOGY
- Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells
- (2010) Erica Novo et al. JOURNAL OF HEPATOLOGY
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- Senescence of Activated Stellate Cells Limits Liver Fibrosis
- (2008) Valery Krizhanovsky et al. CELL
- Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
- (2008) Laurie D. DeLeve et al. HEPATOLOGY
- Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride
- (2008) Ogyi Park et al. HEPATOLOGY
- Liver biopsy: The best, not the gold standard
- (2008) Pierre Bedossa et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now